Omixplus LLC

Sanaria Inc. is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Plasmodium falciparum malaria is responsible for more childhood mortality than any other single infectious agent. The firm s vaccine development efforts are focused on African children, the population most urgently in need of protection. Based in Rockville, Md., it houses a custom-designed and constructed dedicated clinical manufacturing facility for producing its attenuated malaria parasite vaccine. Sanaria Inc. has two ongoing Cooperative Research and Development Agreements (CRADAs) with U.S. government laboratories, a development contract with a biotechnology company, a funded research agreement with a nonprofit, and a services agreement with a nonprofit research institute and a government laboratory.

OriGene Technologies provides innovative technologies for large-scale gene function analyses. OriGene s flagship product is the TrueClone Collection, a searchable source of more than 24,000 human full-length cDNA clones suitable for transfection and protein expression. These cDNAs are suitable for transfection and in vivo or direct in vitro expression. The TrueClone Collection cDNA clones are obtained directly from plasmid cDNA libraries and avoid the sequence errors introduced by other cloning methods. OriGene has commercialized an extensive gene bank of authentic cDNA clones in a standard expression vector. In combination with related gene expression reagents, the company s offerings enable high-throughput functional analysis and the determination of disease specificity. OriGene was founded in 1997 and is based in Rockville, Md.

Meso Scale Diagnostics LLC, based in Rockville, MD, specializes in advanced electrochemiluminescence technology, providing a range of sophisticated instruments and immunoassays for various applications in biomedical research. Their product portfolio includes multiplex kits, assay development tools, and technical resources aimed at enhancing research in areas such as oncology, cardiovascular health, immunology, and neurobiology. The company prides itself on delivering innovative solutions to support scientists across multiple disciplines, including cytokine and chemokine analysis, and offers a wide array of customer services such as bespoke assay development and comprehensive technical literature. Meso Scale Diagnostics is committed to maintaining high standards of quality, evidenced by its ISO certification and detailed product support resources. Generated from the website